Analysis of the cyclin-dependent kinase inhibitor p27kip1 in muscle invasive bladder cancer

Oncology Reports

Volumn 6, Issue 1, 1999, Pages 229-233

  Serth, Jürgen ^a   Kuczyk, Markus ^a   Machtens, Stefan ^a   Bokemeyer, Carsten ^b   Herrmann, Roland ^a   Hartmann, Jörg ^b   Knüchel, Ruth ^c   Jonas, Udo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Bladder cancer; Cell cycle control; Cyclins

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DNA; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER INVASION; CELL CYCLE G1 PHASE; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; POINT MUTATION; SMOOTH MUSCLE;

ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA, NEOPLASM; FEMALE; G1 PHASE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; POINT MUTATION; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 0032608466     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.6.1.229     Document Type: Article

References (25)

1. McGarvey TW and Malkowicz SB: The role of the cell cycle in genitourinary carcinoma. World J Urol 14: 310-317, 1996.
2. Lee CCR, Yamamoto S, Wanibuchi H, Wada S, Sugimura K, Kishimoto T and Fukushima S: Cydin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation. Cancer Res 57: 4765-4776, 1997.
3. Nasmyth K: Viewpoint: putting the cell cycle in order. Science 274: 1643-1645, 1996.
4. Elledge SJ: Cell cycle checkpoints: preventing an identity crisis. Science 274: 1664-1672, 1996.
5. Kawasaki T, Tomita Y, Bilim V, Takeda M, Takahashi K and Kumanishi T: Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations. Int J Cancer 68: 501-505, 1996.
6. Kawamata N, Seriu T, Koeffler HP and Bartram CR: Molecular analysis of the cyclin-dependent kinase inhibitor family: p16 (CDKN2/MTS1/INK4A). p18 (INK4C) and p27 (Kip1) genes in neuroblastomas. Cancer 77: 570-575, 1996.
7. Martin E, Cacheux V, Cave H, Lapierre JM, Le Paslier D and Grandchamp B: Localization of the CDKN4/p27(Kip1) gene to human chromosome 12p12.3. Hum Genet 96: 668-670, 1995.
8. kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 14: 2283-2289, 1997.
9. Toyoshima H and Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74, 1994.
10. Wu G, Fan RS, Li W, Ko TC and Brattain MG: Modulation of cell cycle control by vitamin D3 and its analogue, EB 1089, in human breast cancer cells. Oncogene 15: 1555-1563, 1997.
11. Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M and Giordano A: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57: 3381-3385, 1997.
12. Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillett CE, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O'Hare MJ and Lu X: High level expression of p27(Kip1) and cyclin Dl in some human breast cancer cells: inverse correlation between the expression of p27(Kip1) and degree of malignancy in human breast and colorectal cancers, Proc Natl Acad Sci USA 94: 6380-6385, 1997.
13. Porter PL, Malone KE, Heagerty PJ, Alexander CM, Gatti LA, Firpo EJ, Daling JR and Roberts JM: Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3: 222-225, 1997.
14. Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW and Koeffler HP: p27/Kip1 mutation found in breast cancer. Cancer Res 56: 2400-2404, 1996.
15. Ferrando AA, Balbin M, Pendas AM, Vizoso F, Velasco G and Lopez-Otin C: Mutational analysis of the human cyclin-dependent kinase inhibitor p27Kip1 in primary breast carcinomas. Hum Genet 97: 91-94, 1996.
16. kip1 a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibtion to cell cycle arrest. Genes Dev 8: 9-22, 1994.
17. Kuczyk MA, Serth J, Bokemeyer C, Jonassen J, Arndt H, Paeslack U, Werner M, Tan H-K and Jonas U: Detection of p53 gene alteration in renal-cell cancer by micropreparation techniques of tumor specimens. Int J Cancer 64: 399-406, 1995.
18. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
19. King RW, Deshaies RJ, Peters J-M, et al: How proteolysis drives the cell cycle. Science 274: 1652-1659, 1996.
20. kip1, to regions involved in human cancer. Cancer Res 55: 1199-1205, 1995.
21. Hengst L, Dulic V, Slingerland JM, Lees E and Reed SJ: A cell cycle inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci USA 91: 5291-5295, 1994.
22. Hall M, Bates S and Peters G: Evidence for different modes of action of cyclin-dependent kinase inhibitors. p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 10: 1581-1587, 1995.
23. Blain SW, Monatlvo E and Massague J: Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4, J Biol Chem 272: 25863-25872, 1997.
24. kip1) of cyclin-dependent kinase 4 activation. Cell 79: 487-496, 1994.
25. Yasui W, Kudo Y, Semba S, Yokozaki H and Tahara E: Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res 88: 625-629, 1997.